Investment firm GI Partners closes Clinical Ink acquisition
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical…
05 Aug 2020
Investment firm GI Partners to acquire minority interest in Clinical Ink
Private equity investment firm GI Partners has announced that it will acquire a minority interest in global clinical trial technology Clinical Ink. Clinical Ink, which captures and integrates electronic data…
05 Jun 2020
IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea
The International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital have partnered to conduct a Phase I/II clinical trial of Inovio Pharmaceuticals' Covid-19 vaccine, INO-4800, in South Korea. This…
01 May 2020
Science 37 teams up with AiCure for virtual clinical trials
Virtual clinical trials firm Science 37 has partnered with AiCure, an artificial intelligence (AI) and advanced data analytics firm, for virtual trials technology. The partners will initially leverage a virtual…
23 Mar 2020
Feinstein Institutes announces partnerships for Covid-19 trials
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. The Feinstein Institutes for Medical Research at Northwell Health in…
26 Feb 2020
UBC, Apeiron Biologics to trial coronavirus drug candidate in China
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. A researcher at the University of British Columbia in Canada…
12 Feb 2020
PCI Pharma acquires Bellwyck to expand trial services
PCI Pharma Services has acquired Canadian company Bellwyck Pharma Services to bring its clinical trial services to Canada and continental Europe. Financial terms of the acquisition have not been disclosed.…